Supply Chain

The efforts of CDMOs have been absolutely crucial in the pandemic response. We ask five CDMO gurus how they reacted to COVID-19.

With the threat of COVID-19, vaccine developers needed to enter clinical development and scale-up at unprecedented speed.

DFE Pharma’s Korinde Van Den Heuvel talks to us about what made her company’s new 3D printed tablets possible, and which ills they can cure.

How can logistics companies meet the evolving needs of global clients while maintaining resilience over the long-term?

Pfizer-BioNTech COVID-19 vaccine receives full FDA approval.

Welcome to our Special Series E-book on Advanced Medicine!

Precious metals-bearing catalysts are essential in some pharma processes – but, once they’re spent, they still hold value.

How to streamline a rapidly expanding field? Joe Garrity of Lonza discusses the pain points and easily missed fixes.

How can we maximize the potential and production of potentially life-saving therapies?

Clinical supply chains are inherently dynamic and ambiguous, contributing to a high degree of uncertainty.